A nanotherapeutic strategy to target drug-tolerant cells and overcome EGFR tyrosine kinase inhibitor resistance in lung cancer

Affiliations

• ¹ Department of Pharmacology and Therapeutics, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA.
• ² Department of Biomedical Engineering, University at Buffalo, the State University of New York, Buffalo, New York, USA.
• ³ Cell Stress and Biophysical Oncology Graduate Program, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA.
• ⁴ Fujifilm-VisualSonics Corporation, Toronto, Ontario, Canada.
• ⁵ Department of Oral Oncology, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA.
• ⁶ Department of Pathology, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA.
• ⁷ Cancer Research Institute, School of Medicine, Queens University, Kingston, Ontario, Canada.